Codman Neuro announced today that the U.S. Food and Drug Administration (FDA) has classified the recently initiated medical device correction notice related to the TRUFILL® n-BCA Liquid Embolic System as a Class I recall.
DePuy Synthes Spine, in collaboration with DePuy Synthes Biomaterials, announced today the U.S. launch of CONFORM SHEET™ *±, a hydrated, pliable and totally demineralized cancellous bone matrix that fills voids during posterolateral spinal fusion surgery and provides a natural scaffold for new bone formation.
DePuy Orthopaedics, Inc. (DePuy) and the Court-appointed committee of lawyers representing ASR™ Hip System plaintiffs today announced a settlement agreement to compensate eligible ASR patients in the United States who had surgery to replace their ASR hip, known as revision surgery, as of August 31, 2013
New Cross Pin Solution for Anteromedial Portal Technique and New Cortical Fixation System Debut at Fall AANA Meeting
DePuy Synthes Spine* announced it is expanding its collaboration with Brainlab through the worldwide launch of navigation-ready instrumentation for its leading spine systems, and an exclusive global agreement to co-market Airo® Mobile Intraoperative CT by Brainlab.
DePuy Synthes Spine* announced the global launch of "mPACT" (medialized Posterior Approach Cortical Trajectory), a program that combines implants, education, clinical research and procedural support for posterior mini open fixation and fusion procedures.
DePuy Synthes Spine* announced the launch of the new SYNFLATE Vertebral Balloon as part of its portfolio of procedural solutions for the treatment of painful vertebral compression fractures, internal breaks in spinal bones that commonly occur in people with osteoporosis.
Mitek Sports Medicine, a leader in orthopaedics sports medicine and a part of the DePuy Synthes Companies of Johnson & Johnson, announced the launch of the HEALIX ADVANCE™ KNOTLESS Anchor, a new suture anchor designed to provide optimal knotless fixation for rotator cuff repair.
PARIS, FRANCE– JUNE 13, 2013 – Codman Neuro*, part of DePuy Synthes Companies of Johnson & Johnson, has obtained CE marking for REVIVE SE, a next-generation self-expanding clot removal device for use in treating acute ischemic stroke, the company announced today at the Live Interventional Neuroradiology & Neurosurgery Course (LINNC) in Paris.
DePuy Orthopaedics, Inc., announced its decision to discontinue sales of its ULTAMET® Metal-on-Metal Articulation and COMPLETE™ Ceramic-on-Metal Acetabular Hip System worldwide. The discontinuation will be effective August 31, 2013.